ATE544470T1 - Immuntherapeutische methoden und zusammensetzungen - Google Patents

Immuntherapeutische methoden und zusammensetzungen

Info

Publication number
ATE544470T1
ATE544470T1 AT01929778T AT01929778T ATE544470T1 AT E544470 T1 ATE544470 T1 AT E544470T1 AT 01929778 T AT01929778 T AT 01929778T AT 01929778 T AT01929778 T AT 01929778T AT E544470 T1 ATE544470 T1 AT E544470T1
Authority
AT
Austria
Prior art keywords
antigen presenting
presenting cells
compositions
relates
immunotherapeutic methods
Prior art date
Application number
AT01929778T
Other languages
English (en)
Inventor
James Dobbie
Original Assignee
Lamellar Biomedical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lamellar Biomedical Ltd filed Critical Lamellar Biomedical Ltd
Application granted granted Critical
Publication of ATE544470T1 publication Critical patent/ATE544470T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT01929778T 2000-03-24 2001-03-26 Immuntherapeutische methoden und zusammensetzungen ATE544470T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0007150.6A GB0007150D0 (en) 2000-03-24 2000-03-24 Immunotherapeutic methods and compositions
PCT/GB2001/001936 WO2001072277A2 (en) 2000-03-24 2001-03-26 Immunotherapeutic methods and compositions

Publications (1)

Publication Number Publication Date
ATE544470T1 true ATE544470T1 (de) 2012-02-15

Family

ID=9888324

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01929778T ATE544470T1 (de) 2000-03-24 2001-03-26 Immuntherapeutische methoden und zusammensetzungen

Country Status (13)

Country Link
US (2) US20040110695A1 (de)
EP (1) EP1267924B1 (de)
JP (1) JP2004517031A (de)
AT (1) ATE544470T1 (de)
AU (2) AU5646101A (de)
CA (1) CA2404325C (de)
DK (1) DK1267924T3 (de)
ES (1) ES2382070T3 (de)
GB (1) GB0007150D0 (de)
NO (1) NO333157B1 (de)
NZ (1) NZ522058A (de)
PT (1) PT1267924E (de)
WO (1) WO2001072277A2 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0007150D0 (en) * 2000-03-24 2000-05-17 Lamellar Therapeutics Limited Immunotherapeutic methods and compositions
GB0207653D0 (en) * 2002-04-03 2002-05-15 Lamellar Therapeutics Ltd Methods of using lamellar bodies for therapeutic purposes
JP4545151B2 (ja) * 2003-02-06 2010-09-15 シーラス コーポレイション 非食細胞中への侵入について減弱化されているリステリア、そのリステリアを含むワクチン、およびそれらの使用法
US11324698B2 (en) * 2003-08-28 2022-05-10 Vgsk Technologies, Inc. Sterically stabilized carrier for aerosol therapeutics, compositions and methods for treating the respiratory tract of a mammal
PL1667693T3 (pl) * 2003-09-25 2015-12-31 Lamellar Biomedical Ltd Kompozycje i sposoby wykorzystywania ciał blaszkowatych do celów terapeutycznych
GB0322448D0 (en) * 2003-09-25 2003-10-29 Lamellar Therapeutics Ltd Using lamellar bodies to modify linear biological macro molecules
CN1980638B (zh) * 2004-07-07 2011-10-12 国立血清研究所 用糖脂稳定基于脂质的佐剂制剂的组合物和方法
US7465312B2 (en) 2006-05-02 2008-12-16 Green Medical, Inc. Systems and methods for treating superficial venous malformations like spider veins
US20070299431A1 (en) 2006-05-02 2007-12-27 Green Medical, Inc. Systems and methods for treating superficial venous malformations like spider veins
WO2011002239A2 (ko) * 2009-07-01 2011-01-06 주식회사이언메딕스 포유류의 유핵세포에서 유래된 마이크로베시클 및 이의 용도
CN103002879B (zh) 2010-07-01 2016-04-20 阿昂梅迪克斯公司 来自细胞原生质体的微泡及其应用
JP6100762B2 (ja) * 2011-06-02 2017-03-22 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 膜で被包されたナノ粒子および使用方法
WO2015021390A2 (en) 2013-08-08 2015-02-12 The Regents Of The University Of California Nanoparticles leverage biological membranes to target pathogens for disease treatment and diagnosis
US20170000875A1 (en) 2013-12-02 2017-01-05 Arytha Biosciences, Llc Toxoid preparation and uses thereof
CN106163504B (zh) 2014-03-20 2021-02-09 加利福尼亚大学董事会 水凝胶毒素-吸收或结合纳米颗粒
WO2015187502A1 (en) 2014-06-02 2015-12-10 Cellics Therapeutics, Inc. Use of nanoparticles coated with red blood cell membranes to treat hemolytic diseases and disorders
WO2016109306A1 (en) 2015-01-02 2016-07-07 Cellics Therapeutics, Inc. Use of nanoparticles coated with red blood cell membranes to enable blood transfusion
US10610493B2 (en) 2015-04-29 2020-04-07 The Regents Of The University Of California Detoxification using nanoparticles
WO2017048860A1 (en) 2015-09-14 2017-03-23 Vgsk Technologies, Inc. A sterically stabilized carrier for subcutaneous, sublingual and oral therapeutics, compositions and methods for treating a mammal
EP3632410A1 (de) 2018-10-05 2020-04-08 Lamellar Biomedical Limited Lipidische polynukleotidträger für die zellabgabe
EP3692984A1 (de) 2019-02-08 2020-08-12 Deutsches Krebsforschungszentrum, Stiftung des öffentlichen Rechts Annexinbeschichtete partikel
AU2022270670A1 (en) 2021-05-05 2023-11-30 Nejat Duzgunes Liposome-encapsulated corticosteriods inhibit sars-cov-2 replication and reduces lung inflammation

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5925375A (en) * 1987-05-22 1999-07-20 The Liposome Company, Inc. Therapeutic use of multilamellar liposomal prostaglandin formulations
US5403592A (en) * 1987-08-25 1995-04-04 Macnaught Pty Limited Lubricant composition for rheumatism
US5006343A (en) * 1988-12-29 1991-04-09 Benson Bradley J Pulmonary administration of pharmaceutically active substances
FR2645878B1 (fr) * 1989-04-17 1994-02-25 Institut Nal Sante Recherc Medic Sequences nucleotidiques d'actinomycetales, applications a la synthese ou a la detection d'acides nucleiques, produits d'expression de ces sequences et application en tant que compositions immunogenes
US5088499A (en) * 1989-12-22 1992-02-18 Unger Evan C Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same
AU665764B2 (en) * 1991-05-29 1996-01-18 Baxter International Inc. Methods and compositions for the prevention, diagnosis, and treatment of inflammatory serosal disease and related conditions
JPH05339169A (ja) * 1992-03-03 1993-12-21 Dai Ichi Seiyaku Co Ltd 経口ワクチン
US5543152A (en) * 1994-06-20 1996-08-06 Inex Pharmaceuticals Corporation Sphingosomes for enhanced drug delivery
US5462752A (en) * 1994-07-28 1995-10-31 Prp, Inc. Inhibition of platelet binding
US5643599A (en) * 1995-06-07 1997-07-01 President And Fellows Of Harvard College Intracellular delivery of macromolecules
EP0840622A4 (de) * 1995-07-21 2003-01-02 Aventis Pharma Inc Adeno-assoziierte virusliposomen und ihre verwendung zur transfektion von dendritischen zellen zur stimulation spezifischer immunität
ATE491465T1 (de) * 1997-05-08 2011-01-15 Oncothyreon Inc Verfahren zur gewinnung aktivierter t-zellen und mit antigen-inkubierten antigen-präsentierender zellen
GB9807298D0 (en) * 1998-04-03 1998-06-03 Britannia Pharmaceuticals Ltd Medicament
EP0976403A1 (de) * 1998-07-30 2000-02-02 Stichting Instituut voor Dierhouderij en Diergezondheid (ID-DLO) Adjuvans das ein Lungensurfactant enthält
US6290987B1 (en) * 1998-09-27 2001-09-18 Generex Pharmaceuticals, Inc. Mixed liposome pharmaceutical formulation with amphiphiles and phospholipids
US6193997B1 (en) * 1998-09-27 2001-02-27 Generex Pharmaceuticals Inc. Proteinic drug delivery system using membrane mimetics
GB0007150D0 (en) * 2000-03-24 2000-05-17 Lamellar Therapeutics Limited Immunotherapeutic methods and compositions
GB0207653D0 (en) * 2002-04-03 2002-05-15 Lamellar Therapeutics Ltd Methods of using lamellar bodies for therapeutic purposes
GB0322448D0 (en) * 2003-09-25 2003-10-29 Lamellar Therapeutics Ltd Using lamellar bodies to modify linear biological macro molecules

Also Published As

Publication number Publication date
EP1267924B1 (de) 2012-02-08
AU2001256461B2 (en) 2005-06-30
WO2001072277A3 (en) 2002-06-13
ES2382070T3 (es) 2012-06-05
NZ522058A (en) 2005-05-27
US20040110695A1 (en) 2004-06-10
EP1267924A2 (de) 2003-01-02
CA2404325C (en) 2012-06-12
US20080069866A1 (en) 2008-03-20
NO20024571D0 (no) 2002-09-24
AU5646101A (en) 2001-10-08
PT1267924E (pt) 2012-05-24
WO2001072277A2 (en) 2001-10-04
JP2004517031A (ja) 2004-06-10
GB0007150D0 (en) 2000-05-17
CA2404325A1 (en) 2001-10-04
DK1267924T3 (da) 2012-05-29
NO20024571L (no) 2002-10-14
NO333157B1 (no) 2013-03-18

Similar Documents

Publication Publication Date Title
ATE544470T1 (de) Immuntherapeutische methoden und zusammensetzungen
PT2351579T (pt) Vacinas polipeptídicas para proteção ampla contra linhagens meningocócicas hipervirulentas
NZ331651A (en) BSW17 peptide immunogens for vaccination against and treatment of allergy
IS4518A (is) Nýtt lyfjaform fyrir bóluefni
AU6632496A (en) Cell derived antigen presenting vesicles
WO2005037190A3 (en) Multiplex vaccines
KR950700758A (ko) 비-이온성 계면활성제 소포를 함유하는 백신(Vaccines containing non ionic surfactant vesicles)
GB0130123D0 (en) Outer membrane vesicle vaccine and its preparation
AU3847801A (en) Proteosome influenza vaccine
OA09800A (en) Vaccine compositions containing liposomes.
TW200510538A (en) Functionally reconstituted viral membranes containing adjuvant
GR3017778T3 (en) Immunogenic complexes, in particular iscoms.
ES2177927T3 (es) Composicion para provocar una reaccion inmunologica a un determinante antigenico no proteinico.
DE60137347D1 (de) Neuer immunogener komplex
WO2004030616A3 (en) Ii-KEY/ANTIGENIC EPITOPE HYBRID PEPTIDE VACCINES
AU6078399A (en) Ligand presenting assembly (lpa), method of preparation and uses thereof
WO2004033483A3 (en) Liposomal system and method of using same
ATE385809T1 (de) Saponin-zusammensetzungen und deren verwendung
WO1999047102A3 (en) Methods for enhanced antigen presentation on antigen-presenting cells and compositions produced thereby
BR9905780A (pt) Antìgenos vacinais de leptospira para prevenção da laptospirose
Guan Development of liposomal antigen delivery system for synthetic muc1 peptides